The people
What they build
Open roles via the TechTO Job Board
Working at BioSymetrics
Browse open roles across the community on the TechTO Job Board — Canada’s most connected tech network. BioSymetrics’s roles show up here whenever they post.
Open roles on the TechTO Job Board ↗Or their own careers page: biosymetrics.com/careers ↗Jobs live on jobs.techto.org — the only structured source. We link to it rather than scraping career sites, so the board is always the source of truth.
On the TechTO stage
Gabriel Musso of BioSymetrics presents What AI can and can’t do in Health Care
Watch on YouTube ↗Shiva Amiri of BioSymetrics presents Fools Rush In: How not to fall too fast for Machine Learning
Watch on YouTube ↗Every talk is searchable — ask the archive about BioSymetrics ↗
About
BioSymetrics puts the disease phenotype rather than the gene at the centre of target discovery. Its Elion platform combines large clinical datasets, machine learning and wet-lab validation in zebrafish with CRISPR and computer vision, so a computational hit is tested experimentally before it advances. Programs span familial dilated cardiomyopathy, atherosclerosis and epilepsy. The company is headquartered in Huntington, New York and is remote-first, with team clusters in Boston, Toronto and San Francisco.
Backers
No funding is confirmed by any citable source; figures appear only in database aggregators
Quick answers
What does BioSymetrics do?
It integrates clinical and experimental data with machine learning to find drug targets, then validates them experimentally using zebrafish, CRISPR and computer vision.
What is the Elion platform?
BioSymetrics' phenomics platform, which combines electronic medical record data, machine learning and wet-lab validation rather than treating computational hits as final.
Where is BioSymetrics based?
Huntington, New York, operating remote-first with team clusters in Boston, Toronto and San Francisco.